Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 4
1953 1
1954 8
1955 4
1956 9
1957 5
1958 11
1959 7
1961 2
1964 8
1965 18
1966 46
1967 58
1968 68
1969 89
1970 123
1971 138
1972 160
1973 226
1974 208
1975 350
1976 330
1977 292
1978 291
1979 317
1980 338
1981 391
1982 437
1983 512
1984 607
1985 597
1986 696
1987 708
1988 780
1989 894
1990 1019
1991 1022
1992 1137
1993 1290
1994 1375
1995 1469
1996 1580
1997 1616
1998 1821
1999 1971
2000 2091
2001 2240
2002 2400
2003 2699
2004 2824
2005 3231
2006 3539
2007 3736
2008 3998
2009 4346
2010 4800
2011 5081
2012 5347
2013 5645
2014 5680
2015 5681
2016 5956
2017 6521
2018 6519
2019 6518
2020 9453
2021 9798
2022 8646
2023 7019
2024 3069

Text availability

Article attribute

Article type

Publication date

Search Results

131,366 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Houge-Janssens syndrome 2"
Page 1
Syndromic Craniosynostosis.
Sawh-Martinez R, Steinbacher DM. Sawh-Martinez R, et al. Clin Plast Surg. 2019 Apr;46(2):141-155. doi: 10.1016/j.cps.2018.11.009. Clin Plast Surg. 2019. PMID: 30851747 Review.
Management strategies for syndromic craniosynostosis patients require multidisciplinary subspecialty teams to provide optimal care for complex reconstructive approaches. The most common craniosynostosis syndromes include Apert (FGFR2), Crouzon (FGFR2), Muenke (FGFR3 …
Management strategies for syndromic craniosynostosis patients require multidisciplinary subspecialty teams to provide optimal care fo …
Syndrome Differentiation and Treatment Regularity in Traditional Chinese Medicine for Type 2 Diabetes: A Text Mining Analysis.
Dou Z, Xia Y, Zhang J, Li Y, Zhang Y, Zhao L, Huang Z, Sun H, Wu L, Han D, Liu Y. Dou Z, et al. Front Endocrinol (Lausanne). 2021 Dec 23;12:728032. doi: 10.3389/fendo.2021.728032. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 35002950 Free PMC article. Review.
METHODS: Taking randomized controlled trials (RCTs) on the treatment of T2DM in TCM as the research theme, we searched for full-text literature in three major clinical databases, including CNKI, Wan Fang, and VIP, published between 1990 and 2020. ...Most TCM synd …
METHODS: Taking randomized controlled trials (RCTs) on the treatment of T2DM in TCM as the research theme, we searched for full-text …
The syndrome of irreversible lithium-effectuated neurotoxicity.
Adityanjee, Munshi KR, Thampy A. Adityanjee, et al. Clin Neuropharmacol. 2005 Jan-Feb;28(1):38-49. doi: 10.1097/01.wnf.0000150871.52253.b7. Clin Neuropharmacol. 2005. PMID: 15714160 Review.
OBJECTIVES: Persistent sequelae of lithium intoxication gained clinical attention in the 1980s and were named Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT). The authors review the published cases of SILENT reported in the literature and discuss …
OBJECTIVES: Persistent sequelae of lithium intoxication gained clinical attention in the 1980s and were named Syndrome of Irre …
Megestrol acetate for treatment of anorexia-cachexia syndrome.
Ruiz Garcia V, López-Briz E, Carbonell Sanchis R, Gonzalvez Perales JL, Bort-Marti S. Ruiz Garcia V, et al. Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD004310. doi: 10.1002/14651858.CD004310.pub3. Cochrane Database Syst Rev. 2013. PMID: 23543530 Free PMC article. Review.
BACKGROUND: This is an updated version of a previously published review in The Cochrane Library (2005, Issue 2) on 'Megestrol acetate for the treatment of anorexia-cachexia syndrome'. ...SELECTION CRITERIA: Studies were included in the review if they assessed MA com …
BACKGROUND: This is an updated version of a previously published review in The Cochrane Library (2005, Issue 2) on 'Megestrol acetate …
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kälviäinen R, Mattson R, French JA, Perucca E, Tomson T; ILAE Subcommission on AED Guidelines. Glauser T, et al. Epilepsia. 2013 Mar;54(3):551-63. doi: 10.1111/epi.12074. Epub 2013 Jan 25. Epilepsia. 2013. PMID: 23350722 Free article. Review.
The prior analysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were analyzed using a noninferiority approach, (2) the definiti …
The prior analysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and bo …
Pulmonary Alveolar Proteinosis Syndrome.
Kelly A, McCarthy C. Kelly A, et al. Semin Respir Crit Care Med. 2020 Apr;41(2):288-298. doi: 10.1055/s-0039-3402727. Epub 2020 Apr 12. Semin Respir Crit Care Med. 2020. PMID: 32279299 Review.
Pulmonary alveolar proteinosis (PAP) is a syndrome characterized by progressive accumulation of pulmonary surfactant. ...In primary PAP, the most common cause is autoimmune PAP, which accounts for over 90% of all PAP syndrome. The pathogenesis is driven by reduced G …
Pulmonary alveolar proteinosis (PAP) is a syndrome characterized by progressive accumulation of pulmonary surfactant. ...In primary P …
Targeting PP2A for cancer therapeutic modulation.
Ronk H, Rosenblum JS, Kung T, Zhuang Z. Ronk H, et al. Cancer Biol Med. 2022 Nov 1;19(10):1428-39. doi: 10.20892/j.issn.2095-3941.2022.0330. Cancer Biol Med. 2022. PMID: 36342229 Free PMC article. Review.
LB100, a water-soluble, small-molecule competitive inhibitor of PP2A, has shown particular promise as a chemo- and radio-sensitizing agent. Preclinical success has led to a profusion of clinical trials on LB100 adjuvant therapies, including a phase I trial in extens …
LB100, a water-soluble, small-molecule competitive inhibitor of PP2A, has shown particular promise as a chemo- and radio-sensitizing agent. …
Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial.
Kjellberg A, Abdel-Halim L, Hassler A, El Gharbi S, Al-Ezerjawi S, Boström E, Sundberg CJ, Pernow J, Medson K, Kowalski JH, Rodriguez-Wallberg KA, Zheng X, Catrina S, Runold M, Ståhlberg M, Bruchfeld J, Nygren-Bonnier M, Lindholm P. Kjellberg A, et al. BMJ Open. 2022 Nov 2;12(11):e061870. doi: 10.1136/bmjopen-2022-061870. BMJ Open. 2022. PMID: 36323462 Free PMC article.
This randomised, placebo-controlled clinical trial will explore HBOT as a potential treatment for long COVID-19. ...The main secondary objective is to evaluate whether HBOT improves endothelial function, objective physical performance and short-term HRQoL. ME …
This randomised, placebo-controlled clinical trial will explore HBOT as a potential treatment for long COVID-19. ...The …
North American Envenomation Syndromes.
Warpinski GP, Ruha AM. Warpinski GP, et al. Emerg Med Clin North Am. 2022 May;40(2):313-326. doi: 10.1016/j.emc.2022.01.006. Emerg Med Clin North Am. 2022. PMID: 35461625 Review.
This review discusses the distinct envenomation syndromes produced by North American species of snakes and arthropods, specifically the Crotalinae subfamily of snakes, which includes cottonmouths, copperheads, and rattlesnakes; coral snakes; Latrodectus and Loxosceles spec …
This review discusses the distinct envenomation syndromes produced by North American species of snakes and arthropods, specifically t …
Cannabinoid therapy in epilepsy.
Billakota S, Devinsky O, Marsh E. Billakota S, et al. Curr Opin Neurol. 2019 Apr;32(2):220-226. doi: 10.1097/WCO.0000000000000660. Curr Opin Neurol. 2019. PMID: 30676535 Review.
PURPOSE OF REVIEW: To review the history, pharmacology, and clinical science of cannabidiol (CBD) in the treatment of epilepsy. ...SUMMARY: Identification of CBD, delta9-THC, and the endocannabinoid system in the mid-20th century has led to advancement of cannabis-based th …
PURPOSE OF REVIEW: To review the history, pharmacology, and clinical science of cannabidiol (CBD) in the treatment of epilepsy. ...SU …
131,366 results
You have reached the last available page of results. Please see the User Guide for more information.